Victory Capital Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $227K | Sell |
12,160
-85
| -0.7% | -$1.58K | ﹤0.01% | 2227 |
|
|
2025
Q1 | $235K | Sell |
12,245
-552,988
| -98% | -$10.6M | ﹤0.01% | 2188 |
|
|
2024
Q4 | $20.4M | Sell |
565,233
-22,014
| -4% | -$793K | 0.02% | 840 |
|
|
2024
Q3 | $24.9M | Buy |
587,247
+183,877
| +46% | +$7.8M | 0.02% | 772 |
|
|
2024
Q2 | $16.3M | Buy |
403,370
+389,632
| +2,836% | +$15.7M | 0.02% | 887 |
|
|
2024
Q1 | $486K | Buy |
13,738
+254
| +2% | +$8.99K | ﹤0.01% | 1990 |
|
|
2023
Q4 | $399K | Sell |
13,484
-85,256
| -86% | -$2.52M | ﹤0.01% | 2057 |
|
|
2023
Q3 | $2.05M | Buy |
98,740
+1,130
| +1% | +$23.5K | ﹤0.01% | 1387 |
|
|
2023
Q2 | $2.4M | Buy |
97,610
+6,407
| +7% | +$157K | ﹤0.01% | 1343 |
|
|
2023
Q1 | $3.7M | Buy |
91,203
+16,150
| +22% | +$656K | ﹤0.01% | 1261 |
|
|
2022
Q4 | $3.37M | Buy |
75,053
+9,573
| +15% | +$430K | ﹤0.01% | 1295 |
|
|
2022
Q3 | $3.13M | Sell |
65,480
-37,445
| -36% | -$1.79M | ﹤0.01% | 1348 |
|
|
2022
Q2 | $6.09M | Sell |
102,925
-110,964
| -52% | -$6.57M | 0.01% | 1203 |
|
|
2022
Q1 | $24.6M | Sell |
213,889
-43,372
| -17% | -$4.98M | 0.02% | 809 |
|
|
2021
Q4 | $38.7M | Buy |
257,261
+93,062
| +57% | +$14M | 0.04% | 653 |
|
|
2021
Q3 | $19.6M | Buy |
164,199
+28,941
| +21% | +$3.45M | 0.02% | 905 |
|
|
2021
Q2 | $13.2M | Sell |
135,258
-15,129
| -10% | -$1.47M | 0.01% | 1041 |
|
|
2021
Q1 | $13.3M | Sell |
150,387
-14,101
| -9% | -$1.24M | 0.01% | 1057 |
|
|
2020
Q4 | $15.7M | Buy |
164,488
+32,350
| +24% | +$3.1M | 0.02% | 973 |
|
|
2020
Q3 | $15M | Buy |
132,138
+119,923
| +982% | +$13.6M | 0.02% | 917 |
|
|
2020
Q2 | $1.21M | Sell |
12,215
-14,901
| -55% | -$1.47M | ﹤0.01% | 1639 |
|
|
2020
Q1 | $1.74M | Buy |
27,116
+13,427
| +98% | +$864K | ﹤0.01% | 1653 |
|
|
2019
Q4 | $816K | Buy |
13,689
+2,269
| +20% | +$135K | ﹤0.01% | 1799 |
|
|
2019
Q3 | $674K | Buy |
+11,420
| New | +$674K | ﹤0.01% | 1796 |
|